Measurement of Iohexol Plasma Clearance in Patients Leaving ICU After Acute Renal Failure
Measurement of Iohexol Plasma Clearance in Patients Leaving ICU After Acute Renal Failure
IOXSOR study's purpose to determine the frequency of non resolutive renal failure (estimated by the clearance of iohexol) at end of stay in ICU patients who have had acute renal failure episode.
Inclusion Criteria:
ICU stay > 7 days
Having presented during the stay renal failure stage 2 or 3 Kidney Disease Improving Global Outcomes (KDIGO)
Steady improvement of renal function before the ICU discharge :
Expected discharge ICU within 48 hours :
Informed consent signed by the patient, where not possible by the person of trust or the family if present. Written consent by the patient will be obtained as soon as deemed possible.
Exclusion Criteria: